Back
Sarepta Therapeutics Vs. Summit Therapeutics Industry Stock Comparison
Sell
42
SRPT
Sarepta Therapeutics
Last Price:
$119.85
Seasonality Move:
9.24%
Sell
34
SMMT
Summit Therapeutics
Last Price:
$17.85
Seasonality Move:
13.77%
Sell
42
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $121.50. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $18.21. The Score for SMMT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $121.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $18.21Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 47.71 | Sell |
Chaikin Money Flow: | -244699 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (118.28 - 130.04) | Sell |
Bollinger Bands (100): | (118.1 - 134.36) | Sell |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 47.51 | Sell |
Chaikin Money Flow: | -1110770 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.82 - 18.98) | Sell |
Bollinger Bands (100): | (14.19 - 22.73) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.49 | Buy |
20-day SMA: | 124.81 | Sell |
50-day SMA: | 122.83 | Sell |
200-day SMA: | 129.64 | Sell |
8-day EMA: | 122.13 | Sell |
20-day EMA: | 122.75 | Sell |
50-day EMA: | 123.43 | Sell |
200-day EMA: | 125.83 | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.37 | Sell |
20-day SMA: | 18.26 | Sell |
50-day SMA: | 19.36 | Sell |
200-day SMA: | 12.33 | Buy |
8-day EMA: | 18.5 | Sell |
20-day EMA: | 18.52 | Sell |
50-day EMA: | 18.73 | Sell |
200-day EMA: | 13.86 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.
Sarepta Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |